Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.93/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93 |
Version | 20190510 |
Status | active |
Date | 2019-05-10T01:00:56-04:00 |
Name | CPICRxNORMAbacavirSCDG |
Title | CPIC RxNORM abacavir SCDG |
Experimental | False |
Realm | us |
Authority | hl7 |
Description | We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are are seen with systemically administered medications. Elimu OID: 2019.05.13.10.35 |
Purpose | (Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Data Element Scope: 'None'),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Exclusion Criteria: 'None) |
No resources found
CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1196.93",
"meta" : {
"versionId" : "8",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "Elimu Informatics Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-02-14"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2019-05-10"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1196.93"
}
],
"version" : "20190510",
"name" : "CPICRxNORMAbacavirSCDG",
"title" : "CPIC RxNORM abacavir SCDG",
"status" : "active",
"experimental" : false,
"date" : "2019-05-10T01:00:56-04:00",
"publisher" : "Elimu Informatics Steward",
"description" : "We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are are seen with systemically administered medications.\nElimu OID: 2019.05.13.10.35",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Data Element Scope: 'None'),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having abacavir as an ingredient),(Exclusion Criteria: 'None)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1163058",
"display" : "abacavir / Lamivudine / Zidovudine Oral Product"
},
{
"code" : "1163059",
"display" : "abacavir / Lamivudine / Zidovudine Pill"
},
{
"code" : "1163060",
"display" : "abacavir / Lamivudine Oral Product"
},
{
"code" : "1163061",
"display" : "abacavir / Lamivudine Pill"
},
{
"code" : "1163062",
"display" : "abacavir Oral Liquid Product"
},
{
"code" : "1163063",
"display" : "abacavir Oral Product"
},
{
"code" : "1163064",
"display" : "abacavir Pill"
},
{
"code" : "1546884",
"display" : "abacavir / dolutegravir / Lamivudine Oral Product"
},
{
"code" : "1546885",
"display" : "abacavir / dolutegravir / Lamivudine Pill"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:2d4a076d-8ece-4650-a073-a7e7fc7df0ef",
"timestamp" : "2024-12-10T07:37:59-05:00",
"total" : 9,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1163058",
"display" : "abacavir / lamivudine / zidovudine Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1163059",
"display" : "abacavir / lamivudine / zidovudine Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1163060",
"display" : "abacavir / lamivudine Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1163061",
"display" : "abacavir / lamivudine Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1163062",
"display" : "abacavir Oral Liquid Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1163063",
"display" : "abacavir Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1163064",
"display" : "abacavir Pill"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1546884",
"display" : "abacavir / dolutegravir / lamivudine Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1546885",
"display" : "abacavir / dolutegravir / lamivudine Pill"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.